Multi-center Phase IB Trial of ACY-1215 (Ricolinostat) Combined With Nab-paclitaxel in Unresectable or Metastatic Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Ricolinostat (Primary) ; Paclitaxel
- Indications Breast cancer; Male breast cancer
- Focus Adverse reactions
- 12 Feb 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Oct 2018.
- 17 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 18 Dec 2015 New trial record